"Flanders vaccine" to assure leading position

April 23, 2015 News BioVox

Flemish Minister of Welfare Jo Vandeurzen launches “Flanders Vaccine” in Diepenbeek. This is a new innovation platform where knowledge centers, companies and organizatios that are active in R&D of vaccines, can meet. Belgium has a strong reputation when it comes to the development of vaccines. “Think of the vaccines against hepatitis B, hepatitis A, HPV and ebola”, says Prof. Dr. Pierre Van Damme (VAXINFECTIO, University of Antwerp).The knowledge and experience of VAXINFECTO (University of Antwerp), PROVAKS (Ghent University), FlandersBio, BioMaric (Zwijnaarde), BIOMED and LifeTechLimburg (University of Hasselt) is now centralized. This assures and reinforces the leading position for the development and improvement of vaccines.


BioVox
BioVox

With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!

All posts